1 |
Mahesh, C., Paras, J., Sachin, C., Rajesh, S. & Pradeep, V., Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int. J. Pharmaceutics, 304, 178-184 (2005)
DOI
ScienceOn
|
2 |
Joon Yun, A., Patrick, Y.L. & Kimberly, A.B., Clinical benefits of hydration and volume expansion in a wide range of illnesses may be attributable to reduction of sympathovagal ratio. Med.l Hypotheses, 64(3), 646-650 (2005)
DOI
ScienceOn
|
3 |
Brahma, N.S. & Kwon H, K., Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Controlled Release, 63(3), 235-259 (2000)
DOI
ScienceOn
|
4 |
Torrado, S., Prada, P., Paloma M. de la Torre & Torrado, S., Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials, 25(5), 917-923 (2004)
DOI
ScienceOn
|
5 |
Eytan, A., Klausner, E.L., Michael, F. & Amnon, H., Expandable gastroretentive dosage forms. J. Controlled Release, 90(2), 143-162 (2003)
DOI
ScienceOn
|
6 |
Campbell, IW., Management of Type2 diabetes mellitus with special reference to Metformin HCl therapy. Diabetes Metabolism, 191-196 (1991)
|
7 |
Groop, LC., Sulfonylureas in NIDDM. Diabetes care, 740-751 (1992)
|
8 |
Davidson, MB., An overview of Metformin HCl in the treatment of Type2 diabetes mellitus. American J. Medicine, 99-110 (1997)
|
9 |
Frances, S., John, T.F., John, H.C., Luigi, G.M., Harbans, L.S. & Anne-Marie, S. The use of citric acid to prolong the in vivo gastro-retention of a floating dosage form in the fasted state. J. Pharmaceutics, 308, 8-13 (2006)
DOI
ScienceOn
|
10 |
Davis, S.S., Formulation strategies for absorption windows. Drug Dis. Today., 10, 249-256 (2005)
DOI
ScienceOn
|
11 |
Deshpande, A.A., Rhodes, C.T., Shah, N.H. & Malick, A.W., Controlled-release drug delivery systems for prolonged gastric residence. an overview, Drug Dev. Ind. Pharm., 22(6), 531-539 (1996)
DOI
|
12 |
Klausner, E.A., Lavy, E., Friedman, M., Hoffman, A., Expandable gastroretentive dosage forms. J. Controlled. Release, 90, 143-162 (2003)
DOI
ScienceOn
|
13 |
Antonio, A., Adriana, M.V., Edgard, F.C. & Joaquim, M., Effect of different types of fundoplication on the gastric emptying of liquids and gastric compliance in rats. J. Pediatric Surgery, 40, 1551-1556 (2005)
DOI
ScienceOn
|
14 |
Emmanuel, B.S., Michel, A., Simon, R., Sophie, H., Guillaume, S., Eric L. & Philippe, D., Modalities in Performing Capsule Endoscopy: Does it Influence Gastric Retention? Gastrointestinal Endoscopy, 61, AB160 (2005)
|
15 |
Snoeck, V., Huyghebaert, N., Cox, E., Vermeire, A., Saunders, J., Remon, J. P., Verschooten, F. & Goddeeris, B.M., Gastrointestinal transit time of nondisintegrating radioopaque pellets in suckling and recently weaned piglets. J. Controlled Release, 94(1), 143-153 (2004)
DOI
ScienceOn
|
16 |
Jun, Chen., William, E., Blevins, H.P. & Kinam, P., Gastric retention properties of superporous hydrogel composites. J. Controlled Release, 64(1-3), 39-51 (2000)
DOI
ScienceOn
|
17 |
Thairs, S., Ruck, S., Jackson, S.J., Steele, R.J.C., Feely, L.C., Washington, C. & Washington, N., Effect of dose size, food and surface coating on the gastric residence and distribution of an ion exchange resin. Int. J. Pharmaceutics, 176(1), 47-53 (1998)
DOI
ScienceOn
|
18 |
Nattrass, M., Albert, KGMM., Biguanides. Diabetologia, 14, 17 (1978)
|
19 |
DeFranzo, R.A., Pharmacologic therapy for type 2 diabetes mellitus. Annals of Int. Medicine, 281-303 (1999)
|